Health Canada has cleared the way for ALS patients in that nation to join the ongoing ALSTARS U.S. trial testing therapy ...

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

An update from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics has provided a regulatory update on NUZ-001, its ...

Kv7.2/7.3 channels are voltage-gated potassium channels involved in regulating membrane potential and neuronal excitability.

REDLANDS, Calif.--(BUSINESS WIRE)--The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, ...

SAN FRANCISCO--(BUSINESS WIRE)--Unlearn ®, a pioneering artificial intelligence company, today announced a groundbreaking partnership with German-based APST Research (APST), a leading platform for ALS ...

These research grants, worth up to $1 million each, support early-phase trials that generate important data about things like safety, dosing, and biomarkers to help speed up the availability of ...

LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange ...

NEALS, the world's largest ALS research consortium, has selected the COYA 302 trial and it is now affiliated with NEALS as part of its mission to accelerate the development of new treatments for ...

Analisa Novak is a content producer for CBS News and the Emmy Award-winning "CBS Mornings." She specializes in covering live events and exclusive interviews for the show. Analisa is a United States ...

Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an "amazing" new drug for stopping her disease in its tracks. Raziel Green, 52, an active runner and mother of two, ...